
Ultrabose 0.2mg Tablet
Marketer
Ideal Life Sciences Pvt Ltd
Salt Composition
Voglibose (0.2mg)
Overview Ultrabose 0.2mg Tablet
Diabetol 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. This medication is prescribed when dietary adjustments and other similar treatments prove insufficient in controlling elevated blood glucose. Diabetol 0.2mg should be administered immediately prior to meals. Dosage frequency is determined individually by your physician to optimize blood sugar management. Discontinuing use abruptly is unsafe and may result in dangerously high blood sugar, potentially leading to complications such as renal impairment or vision loss. Treatment success requires adherence to a comprehensive plan incorporating diet, exercise, and weight management, as advised by your doctor. Regular blood glucose monitoring is essential. Common side effects include abdominal discomfort (flatulence, pain), appetite changes, constipation, and diarrhea. Report any persistent or troublesome side effects to your physician. While Diabetol 0.2mg itself doesn't induce hypoglycemia, concurrent use with other diabetes medications (particularly insulin or sulfonylureas) increases this risk. Treatment for hypoglycemic episodes requires simple glucose; table sugar is ineffective. Inform your doctor of any kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation (e.g., Crohn's disease, ulcerative colitis). Pregnant or lactating individuals should consult their physician prior to use. Complete disclosure of all other medications is crucial for safety. Limit alcohol consumption to minimize hypoglycemia risk.
Primary Ingredients of Ultrabose 0.2mg Tablet
No text provided to rephrase.
Uses of Ultrabose 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Ultrabose 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ultrabose 0.2mg tablets should be administered on an empty stomach.
Common Side effects of Ultrabose 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Ultrabose 0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ultrabose 0.2mg Tablet on an empty stomach.
How Ultrabose 0.2mg Tablet works:
Glucodown 0.2mg tablets are used to manage diabetes. They work by blocking the digestive enzymes that process complex carbohydrates, thus limiting the rapid post-meal surge in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Ultrabose 0.2mg Tablet and alcohol is not advisable due to safety concerns.
PregnancySAFE IF PRESCRIBED
Use of Ultrabose 0.2mg tablets during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Ultrabose 0.2mg tablets while breastfeeding is likely safe. Preliminary human studies indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ultrabose 0.2mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Ultrabose 0.2mg tablets cautiously, as dose modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Ultrabose 0.2mg tablets. Dosage modification of Ultrabose 0.2mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Ultrabose 0.2mg Tablet :
Omit any missed Ultrabose 0.2mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Ultrabose 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Active Class | Alpha-glucosidase inhibitors |
